Keywords: atherosclerotic renovascular disease; bipolar renal length; creatinine clearance; proximal lumen Background. Renal impairment is common in patients with atherosclerotic renovascular disease (ARVD), but patency; renal function; renal parenchymal damage; ultrasound its pathogenesis is uncertain. This study investigated whether any relationship existed between renal function and the severity of proximal renal arterial lesions in patients with ARVD.
function of patients with RAO was also further classified although individual patients with ARVD have been with respect to accompanying contralateral disease, as this rescued from dialysis treatment by surgery [12] or provided an important insight into pathogenetic mechanisms. angioplasty, the majority of patients manifest no improvement in renal function, or indeed, some show Statistical analyses progressive renal functional decline, after revascularization. There is now an increasing recognition that, in Patients were stratified into sub-groups based upon their many patients with ARVD, the extent of renal parenresidual patency index; their clinical and investigational chymal injury rather than the severity of proximal characteristics were compared in the context of these subvascular lesions is the chief determinant of renal funcgroups. The angiographic findings were also represented in tional outcome. This study sought to investigate the standard groupings (unilateral/bilateral, RAS <60%, RAS relationship of renal dysfunction to the extent of >60% or RAO), and renal function as well as renal size proximal arterial lesions in a cohort of patients with were also analysed between these groups. Means, standard ARVD. deviations (SD), and median values are displayed where appropriate. Mean renal size for each sub-group was derived from the average ultrasound bipolar renal length (i.e.
Subjects and methods
(right+left)/2) for each patient. Variables were analysed by two-way analysis of variance (ANOVA). When the ANOVA A cohort of 71 patients with varying degrees of ARVD indicated significant differences among patient groups, entered the local renovascular disease database between differences in categorical data were analysed with x2 tests. 1995-1997. They had all been referred with either hyperten-For continuous data, means were compared by t tests. A P sion or chronic renal failure. Renal arterial anatomy was value of less than 0.05 was considered a significant difference. investigated by digital subtraction angiography, the studies A correlation study was used to test the relationship between being interpreted by a single vascular radiologist who was renal function and residual lumen patency. blinded to the renal functional data. The percentage stenosis of any given RAS was estimated by standard methodology; The relationship between standard angiographic of the study was to examine the relationship between renal findings, renal function and ultrasonographic renal size arterial anatomy and renal function at the time of angiograis depicted in Table 1 . The 36 patients with unilateral phy, a simple scoring system for proximal renovascular disease (i.e. insignificant RAS, significant RAS or RAO disease severity was developed which also denoted the residaffecting one kidney, the contralateral vessel being in renal length between patients with unilateral or bilateral RAS, but kidneys with RAO were significantly Where a kidney was supplied by more than one renal artery, the residual patency was estimated from the propor-smaller (e.g. in the 28 patients with unilateral RAO, tionate narrowing of the total arterial supply of that kidney the RAO kidney was 7.68±1.3 cm compared to (e.g. if a kidney was supplied by two arteries, one having 10.02±1.15 cm for the contralateral kidney; 80% RAS and the other being normal, the patency score for P<0.001). These findings suggest that, with the excepthat kidney would be 0.6). Renal function was assessed by tion of kidneys shrunken by RAO, chronic renal creatinine clearance just prior to the angiographic procedure. parenchymal damage is the chief determinant of renal Bipolar renal length of all kidneys was determined by renal dysfunction in patients with ARVD. ultrasound and 24-h urinary protein excretion was also The patency index enabled patients in different renomeasured. Other demographic data including age at presentavascular anatomical categories to be grouped together tion, sex, blood pressure, and presence of other vascular such that comparisons could be made according to disease (angina, myocardial infarction, or cerebrovascular or peripheral vascular disease) were also recorded. The renal overall renovascular disease severity. Table 2 displays the clinical characteristics and basic investigations of the patients, as separated into four sub-groups by patency index. Hypertension (BP >160/90, or receiving treatment) was documented in 90% of patients; 44 (70%) patients had comorbid vascular disease. Patients with residual patency >1.5 had very mild ARVD (e.g. <50% narrowing of only one renal artery) whereas those in patency groups 0.5-0.9 and <0.5 had severe proximal ARVD. As was shown with respect to standard angiographic findings, renal function was completely independent of the severity of proximal ARVD (Figure 1) , and the lack of correlation of creatinine clearance with residual lumen patency (r=0.015) is highlighted in Figure 2 . This was further exemplified by the fact that four patients with lumen patency >1.5 had creatinine clearances of <20 ml/min and yet three patients with lumen patency <0.5 had clearances of >50 ml/min. Similarly, both the mean level of pro- had significantly less comorbid vascular disease than despite having normal or only mild-moderate RAS in the contralateral vessel, whereas three of the four the other patient groups.
Results
As it might have been anticipated that those patients patients with contralateral severe RAS had much better renal function than this, again stressing the importance with RAO would have more advanced renal dysfunction, these were also analysed separately. There were of co-existing renal parenchymal injury in the pathogenesis of renal dysfunction in ARVD. There was a 28 patients with unilateral RAO, and their overall renal function (creatinine clearance 30.3±17.7; range notable trend of mean contralateral (non-RAO) renal size becoming progressively smaller with worsening 3-66 ml/min) was not different from any of the above patency groups. Seventeen of these patients had normal renal function; this supports the relationship of overall renal function with total renal mass, and is in accord-contralateral vessels, seven mild-moderate RAS, and four severe contralateral RAS; even allowing for small ance with the observation that renal atrophy may occur independently of RAS in ARVD [5]. patient numbers, it was still surprising that renal function was very similar in these different sub-groups.
Renal biopsies were only available on four patients who had been suspected of having other co-existing In Table 3 the RAO patients are separated according to the severity of contralateral renovascular disease. It renal disease (two had proteinuria >2 g/day, and the other patients no evident arterial bruits). can be seen that 14 patients with RAO had severe renal dysfunction (creatinine clearance of <25 ml/min) Histopathological analysis revealed focal segmental glomerulosclerosis (one patient), glomerulosclerosis tomy and by residual luminal patency. Although the study was only cross-sectional and the division of and tubular atrophy, compatible with 'ischaemic nephropathy' (two patients), and cholesterol atheroem-patients into sub-groups of differing patency was arbitrary, there was absolutely no relationship between boli (one patient).
proximal renovascular narrowing and overall renal dysfunction. Renal impairment was equally marked in
Discussion
patients with mild proximal ARVD as in those with severe bilateral disease, or in those patients who had unilateral RAO. Kidneys affected by RAO were signi-This study further emphasizes that factors other than the severity of proximal renal vascular lesions are likely ficantly smaller than those with RAS, but just as for renal function, average renal size was not predictive of to contribute to the pathogenesis of renal dysfunction in patients with ARVD, and the findings are therefore the sub-grouping of ARVD severity. Renal histology was only obtained in a minority of patients, but it was consistent with the variability of renal functional outcomes that follow revascularization procedures in these representative of the spectrum of changes described as 'ischaemic nephropathy' [17] . Perhaps the renal paren-patients [13] . Restoration of renal artery patency in patients with high-grade RAS has been possible with chymal damage might be more appropriately termed 'atherosclerotic nephropathy' [18] in some patients, as surgical and angioplasty techniques for many years, and although an overall improvement in renal function intra-renal atheroma, hypertensive damage, and cholesterol emboli may develop independently of the isch-may be seen after revascularization, sub-group analysis usually depicts a disparity in functional outcomes with aemia that would be consequent upon a high-grade stenosis. Such a hypothesis would explain the findings the majority of patients showing no change after revascularization, whereas the remaining patients are of this and other [5, 8, 9, 15 ] studies, as well as the previously described inconsistencies in renal functional equally divided into those manifesting progressive deterioration or definite improvement of renal function outcome seen after revascularization in ARVD.
Proteinuria has recently been shown to be a non- [7] [8] [9] [10] . Patency is not always preserved after angioplasty alone as there is a strong likelihood of re-stenosis, specific marker of this parenchymal damage in patients with ARVD [19] . especially in ostial lesions, but its use in combination with endovascular stenting yields high patency rates
Our findings suggest that underlying renal parenchymal damage is a major determinant of renal dysfunc- [14, 15] and yet a similar stratification of renal functional outcomes [9, 15] . Further, studies with SK-GFR tion in ARVD, and, with the exception of kidneys affected by RAO, it should be considered independ-have confirmed that angioplasty of a tight stenosis usually does not increase individual kidney function in ently of the proximal renal arterial disease in these patients. Studies that help distinguish the varying con-patients with ARVD [6 ]. However, younger patients with fibromuscular dysplasia of the renal artery do tributions of renal ischaemia, hypertensive damage, and intra-renal atherosclerosis to the pathogenesis of show an improved SK-GFR after angioplasty, which could be explained by the presence of healthy renal renal dysfunction in these patients are now required.
Only such clinicopathological clarity will enable appro-parenchyma distal to the stenosis.
It is likely that the pathogenesis of renal dysfunction priate selection of patients, and indeed, those particular kidneys, most likely to benefit from revascularization, in patients with ARVD is multi-factorial. This has been inferred by Caps et al.
[5] who used serial duplex thereby facilitating the chances of optimal long-term renal functional outcome after surgery, angioplasty, or ultrasound to examine factors that determine progression to renal atrophy in a cohort of patients with endovascular stenting in the future. ARVD. The cumulative risk of renal atrophy was greatest in patients with poorly controlled hyperten-References sion; although kidneys with RAS >60% had a high rate of atrophy, the vast majority had not progressed
